Volume | 47,126 |
|
|||||
News | (1) | ||||||
Day High | 1.7499 | Low High |
|||||
Day Low | 1.59 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Avinger Inc | AVGR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.66 | 1.59 | 1.7499 | 1.74 | 1.66 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
320 | 47,126 | US$ 1.65 | US$ 77,798 | - | 1.59 - 18.00 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:36:02 | formt | 188 | US$ 1.80 | USD |
Avinger Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.38M | 1.37M | - | 7.65M | -18.32M | -13.37 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Avinger News
Date | Time | Source | News Article |
---|---|---|---|
6/13/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
6/07/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
5/31/2024 | 12:27 | Edgar (US Regulatory) | Form SD - Specialized disclosure report |
5/31/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
5/24/2024 | 16:18 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
5/16/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
5/15/2024 | 16:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
5/15/2024 | 15:37 | Edgar (US Regulatory) | Form 8-K - Current report |
3/08/2024 | 15:31 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
3/07/2024 | 05:30 | Edgar (US Regulatory) | Form 8-K - Current report |
2/14/2024 | 13:41 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
1/26/2024 | 16:21 | Edgar (US Regulatory) | Form 8-K - Current report |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVGR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.96 | 2.09 | 1.59 | 1.75 | 22,035 | -0.16 | -8.16% |
1 Month | 3.71 | 3.72 | 1.59 | 2.12 | 27,520 | -1.91 | -51.48% |
3 Months | 2.93 | 4.3689 | 1.59 | 2.87 | 17,553 | -1.13 | -38.57% |
6 Months | 3.09 | 5.45 | 1.59 | 3.40 | 35,357 | -1.29 | -41.75% |
1 Year | 8.70 | 18.00 | 1.59 | 9.32 | 532,267 | -6.90 | -79.31% |
3 Years | 17.85 | 63.00 | 1.59 | 11.08 | 654,002 | -16.05 | -89.92% |
5 Years | 69.00 | 75.00 | 1.59 | 13.67 | 2,929,569 | -67.20 | -97.39% |
Avinger Description
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States. |